Author: Jupiter Life Science Consulting

With the recent publication of American Patients First, the Trump administration has provided what it describes as a “blueprint to lower drug prices and reduce patient out-of-pocket costs.” Less a blueprint than a general position document, American Patients First is light on details and heavy...

BOSTON – Dec. 12, 2017 – Jupiter Life Science Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, today announced the acquisition of Alta Bioscience Consulting. Alta is a global provider of advisory services in the development and commercialization of...